The Origin and Memory of Human IgE Responses
人类 IgE 反应的起源和记忆
基本信息
- 批准号:9375287
- 负责人:
- 金额:$ 25.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-15 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAllergensAllergicAllergic DiseaseAntibodiesAntigensApoptoticAtopic DermatitisB-LymphocytesBindingBiologicalBiological MarkersBloodBlood CirculationCD4 Positive T LymphocytesCell Differentiation processCellsChronicDNA sequencingEpigenetic ProcessExtrinsic asthmaGenerationsGenesGenetic TranscriptionGrantHalf-LifeHumanIgEIgG1Immunoglobulin Class SwitchingImmunoglobulin GImmunoglobulin MImmunoglobulin Switch RecombinationIncidenceIndividualInfectionInflammatoryMediatingMemoryMemory B-LymphocyteModelingMolecular ProfilingMusParasitesPathogenicityPatientsPhasePhenotypePlasmaPlasma CellsPlayProcessProductionProliferatingPublic HealthRegulationRiskRoleSequence AnalysisSerumStructure of germinal center of lymph nodeT memory cellT-LymphocyteTherapeuticanti-IgEbasecrosslinkhuman subjectinterestmast cellmemory CD4 T lymphocytemouse modelnovelnovel therapeuticspermissivenessprematurereceptorresponse
项目摘要
Project Summary
IgE antibodies play a central role in allergic diseases due to their ability to bind to high-affinity receptors on
mast cells and induce degranulation upon allergen crosslinking1, 2. In spite of its powerful inflammatory effects,
IgE is the antibody with the lowest serum concentration and the shortest half-life, and IgE-producing B
lymphocytes are extremely rare in humans and mice, suggesting that IgE production is strongly regulated. The
increased incidence of allergic diseases and its detrimental effects on public health brought renewed interest in
understanding the regulation of IgE production. Furthermore, the positive effect of anti-IgE treatment on allergic
asthma and other chronic allergic diseases validated IgE as a therapeutic target3. Studies from mouse models
uncovered several mechanisms that restrain IgE production4, 5. The germinal center (GC) phase of IgE cells is
prematurely terminated, and IgE GC cells do not generate IgE memory cells or long-lived IgE plasma cells6.
Instead, the sequential switching of IgG cells to IgE originates most antigen-specific high affinity IgE plasma
cells6, 7, 8. These findings have brought about a new understanding on the memory of IgE response, that is, that
IgE memory is contained within IgG cells that under appropriate activation, can give rise to IgE plasma cells.
Based on this novel model, we hypothesize that the potential for pathogenic IgE production resides in allergen-
specific “permissive” IgG memory cells that can be activated by “permissive” CD4 memory T cells to switch to
IgE. We propose to determine phenotypic, transcriptional, epigenetic and functional differences between total
and antigen-specific IgG memory cells and CD4 memory T cells from atopic and non-atopic individuals.
Through these studies we hope to identify “permissive” memory B and T cells, and determine the risk of
individuals producing pathogenic IgE. Understanding the regulation of IgE production in human subjects is of
great importance to developing new therapies for allergic diseases.
项目摘要
IgE抗体在过敏性疾病中起着核心作用,这是由于它们能够结合到皮肤上的高亲和力受体。
肥大细胞和诱导脱粒过敏原交联1,2。尽管它有很强的炎症作用,
IgE是血清浓度最低、半衰期最短的抗体,产生IgE的B
淋巴细胞在人类和小鼠中极为罕见,这表明IgE的产生受到强烈的调节。的
过敏性疾病发病率的增加及其对公共卫生的有害影响重新引起了人们对
了解IgE产生的调节。此外,抗IgE治疗对过敏性疾病的积极作用
哮喘和其他慢性过敏性疾病证实IgE是治疗靶点3。小鼠模型研究
发现了几种抑制IgE产生的机制4,5。IgE细胞的生发中心(GC)期是
IgE GC细胞不产生IgE记忆细胞或长寿的IgE浆细胞6。
相反,IgG细胞向IgE的顺序转换产生大多数抗原特异性高亲和力IgE血浆
细胞6,7,8。这些发现对IgE反应的记忆有了新的认识,即:
IgE记忆包含在IgG细胞内,在适当的激活下,可以产生IgE浆细胞。
基于这种新的模型,我们假设致病性IgE产生的可能性存在于过敏原中,
特异性“允许性”IgG记忆细胞,其可被“允许性”CD4记忆T细胞激活以切换至
IgE。我们建议确定表型,转录,表观遗传和功能差异之间的总
以及来自特应性和非特应性个体的抗原特异性IgG记忆细胞和CD4记忆T细胞。
通过这些研究,我们希望能够识别出“允许的”记忆B和T细胞,并确定
产生致病性IgE的个体。了解人类受试者中IgE产生的调节是
对开发过敏性疾病的新疗法具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARIA A CUROTTO DE LAFAILLE其他文献
MARIA A CUROTTO DE LAFAILLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARIA A CUROTTO DE LAFAILLE', 18)}}的其他基金
Cellular and molecular mechanisms of IgE cell memory in allergic responses
过敏反应中IgE细胞记忆的细胞和分子机制
- 批准号:
9891945 - 财政年份:2017
- 资助金额:
$ 25.43万 - 项目类别:
Cellular and molecular mechanisms of IgE cell memory in allergic responses
过敏反应中IgE细胞记忆的细胞和分子机制
- 批准号:
9987208 - 财政年份:2017
- 资助金额:
$ 25.43万 - 项目类别:
相似海外基金
Measurement of serum IgE and identification of allergens in seafood allergic patients
海鲜过敏患者血清IgE测定及过敏原鉴定
- 批准号:
21K13490 - 财政年份:2021
- 资助金额:
$ 25.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of augmentation of contact allergic reactions by irritants and contact allergens
刺激物和接触性过敏原增强接触性过敏反应的机制
- 批准号:
335858052 - 财政年份:2017
- 资助金额:
$ 25.43万 - 项目类别:
Research Grants
Elucidation of conformational epitopes of peanut allergens essential for allergic reactions
阐明过敏反应所必需的花生过敏原的构象表位
- 批准号:
8970024 - 财政年份:2015
- 资助金额:
$ 25.43万 - 项目类别:
Environmental allergens affect the function of allergic inflammatory cells
环境过敏原影响过敏性炎症细胞的功能
- 批准号:
26860758 - 财政年份:2014
- 资助金额:
$ 25.43万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Effects of allergens on dendritic cell function in allergic asthma
过敏原对过敏性哮喘树突状细胞功能的影响
- 批准号:
nhmrc : 303161 - 财政年份:2004
- 资助金额:
$ 25.43万 - 项目类别:
NHMRC Project Grants
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
- 批准号:
8348615 - 财政年份:2001
- 资助金额:
$ 25.43万 - 项目类别:
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
- 批准号:
8522031 - 财政年份:2001
- 资助金额:
$ 25.43万 - 项目类别:
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
- 批准号:
8730013 - 财政年份:2001
- 资助金额:
$ 25.43万 - 项目类别:
ASPERGILLUS ALLERGENS AND ALLERGIC ASPERGILLOSIS
曲霉过敏原和过敏性曲霉病
- 批准号:
6137243 - 财政年份:1998
- 资助金额:
$ 25.43万 - 项目类别:
ASPERGILLUS ALLERGENS AND ALLERGIC ASPERGILLOSIS
曲霉过敏原和过敏性曲霉病
- 批准号:
2462172 - 财政年份:1998
- 资助金额:
$ 25.43万 - 项目类别: